Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Breastfeeding May Lower Risk Of Ovarian Cancer: Study April 8, 2020 Martha Garcia Add Your Comments The findings of new research suggest breastfeeding a baby, even for a short period of time, may reduce a woman’s risk of getting ovarian cancer. While breast feeding for longer periods of time reduced a woman’s risk of ovarian cancer by up to 34%, even three months or less of breastfeeding reduced the risk by about 18%, according to findings published this month in the medical journal JAMA Oncology. Researchers from Harvard Medical School analyzed data on nearly 10,000 women with ovarian cancer, and compared them to 14,000 control subjects participating in the Ovarian Cancer Association Consortium from November 1989 to December 2009. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The study involved questionnaires and interviews to collect data on the women’s breastfeeding history, including duration per child breastfed, age at first and last breastfeeding, and years since last breastfeeding. According to the findings, breastfeeding was associated with a 24% reduced risk of invasive epithelial ovarian cancer. Longer breastfeeding duration and shorter time since the last breastfeeding episode were linked with a further decrease in risk. The researchers determined that breastfeeding for one to three months was associated with an 18% decreased breast cancer risk, while breastfeeding for 12 or more months was linked to a 34% lower risk. Having breastfed more recently was associated with a reduction in risk that lasted for decades. However, researchers determined having breastfed at all led to a benefit lasting for at least 30 days. Compared to women who never breastfed, breastfeeding was linked to a 44% reduced risk of ovarian cancer. Having breastfed at all in the last 30 years decreased a woman’s risk by 17%. More than 200,000 women in the United States are diagnosed with ovarian cancer every year, according to the American Cancer Society. Women who are diagnosed often have a poor prognosis. About 45% of women diagnosed with ovarian cancer survive at least five years after diagnosis. While the relationship between breastfeeding and ovarian cancer is unclear, and the study does not prove a causal link, it does indicate an association between breastfeeding and a reduced risk of ovarian cancer, the researchers determined. “This large study with extensive information on breastfeeding provides epidemiological evidence that breastfeeding, a potentially modifiable factor, may confer significant reduction in ovarian cancer risk, including high-grade serous, the deadliest subtype,” the researchers wrote. Tags: Breast Feeding, Cancer, Ovarian Cancer More Lawsuit Stories Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025 AngioDynamics Lawsuit Claims Xcela Port Catheter Caused Acute Embolism March 19, 2025 Amazon Challenges Responsibility To Notify Customers About Recalled Products March 19, 2025 1 Comments OL April 9, 2020 This was the information I knew in 1971 to convince my wife to nurse our firstborn. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025) Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025) Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)
Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)
Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)